Paul Gould
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paul Gould has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alex Bobik
Baker Heart and Diabetes Institute
1 shared publication - Alexander John McCann
Department of Paediatric Anaesthesia and Pain Management The Royal Children's Hospital Parkville, Melbourne Victoria Australia
1 shared publication - Andrew J. Taylor
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Vic, Australia
1 shared publication - Arthur Mark Richards
Cardiovascular Research Institute, National University Health System, Singapore 117599, Singapore
1 shared publication Cameron Booth
Princess Alexandra Hospital; Brisbane Queensland Australia
1 shared publicationDavid M Kaye
1 shared publication
Latest Publications
- 24 December 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 33 (3) , 565
CIED guideline recommendations in the setting of advisories
- 24 December 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 33 (3) , 565
CIED guideline recommendations in the setting of advisories
- Open Access
- 1 August 2016
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 25, S15
Half-Dose Thrombolysis in Submassive Pulmonary Embolism and Right-Heart Thrombus
- 1 August 2016
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 25, S15
Open AccessHalf-Dose Thrombolysis in Submassive Pulmonary Embolism and Right-Heart Thrombus
- 18 February 2016
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 39 (4) , 382-392
Imaging and Right Ventricular Pacing Lead Position: A Comparison of CT, MRI, and Echocardiography
Right ventricular nonapical (RVNA) pacing may reduce the risk of heart failure. Fluoroscopy is the standard approach to determine lead tip position, but is inaccurate. We compared cardiac computed tomography (CT), magnetic resonance imaging (MRI), two-dimensional and three-dimensional transthoracic echocardiography (TTE), and chest x-ray (CXR) to assess which provides the optimal assessment of right ventricular (RV) lead tip position. Eighteen patients with MRI-conditional pacemakers (10 RVNA and eight apical [RVA] leads) underwent contrast CT, MRI, TTE, and a standard postimplant posteroanterior and lateral CXR. To compare images, the RV was arbitrarily partitioned into three long-axis segments (right ventricular outflow tract, middle, and apex), and two short-axis segments (septal and nonseptal). Agreement between modalities was assessed. RV lead tip position was identified in all patients on CT, TTE, and CXR, but was not identified in seven (39%) patients on MRI due to device-related artifact. Of 10 leads deemed to be nonapical/septal during implant, 70% were identified as nonapical on CXR, 60% on CT, 60% on MRI, and 80% on TTE. On CT imaging only 10% were truly septal, 20% on MRI, 30% on CXR, and 80% on TTE. Agreement was better between modalities when assessing position of the designated RVA leads. During implant leads intended for the septum are not confirmed as such on subsequent imaging, and marked heterogeneity is apparent between modalities. MRI is limited by artifact, and discrepancy exists between TTE and CT in identifying septal lead position. CT gave the clearest definition of lead tip position.
- 18 February 2016
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 39 (4) , 382-392
Imaging and Right Ventricular Pacing Lead Position: A Comparison of CT, MRI, and Echocardiography
Right ventricular nonapical (RVNA) pacing may reduce the risk of heart failure. Fluoroscopy is the standard approach to determine lead tip position, but is inaccurate. We compared cardiac computed tomography (CT), magnetic resonance imaging (MRI), two-dimensional and three-dimensional transthoracic echocardiography (TTE), and chest x-ray (CXR) to assess which provides the optimal assessment of right ventricular (RV) lead tip position. Eighteen patients with MRI-conditional pacemakers (10 RVNA and eight apical [RVA] leads) underwent contrast CT, MRI, TTE, and a standard postimplant posteroanterior and lateral CXR. To compare images, the RV was arbitrarily partitioned into three long-axis segments (right ventricular outflow tract, middle, and apex), and two short-axis segments (septal and nonseptal). Agreement between modalities was assessed. RV lead tip position was identified in all patients on CT, TTE, and CXR, but was not identified in seven (39%) patients on MRI due to device-related artifact. Of 10 leads deemed to be nonapical/septal during implant, 70% were identified as nonapical on CXR, 60% on CT, 60% on MRI, and 80% on TTE. On CT imaging only 10% were truly septal, 20% on MRI, 30% on CXR, and 80% on TTE. Agreement was better between modalities when assessing position of the designated RVA leads. During implant leads intended for the septum are not confirmed as such on subsequent imaging, and marked heterogeneity is apparent between modalities. MRI is limited by artifact, and discrepancy exists between TTE and CT in identifying septal lead position. CT gave the clearest definition of lead tip position.
- 10 January 2006
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 4 (1) , 97-109
Biventricular pacing in heart failure: a review
Biventricular pacing has been an exciting recent advance in the management of drug-refractory heart failure. This new therapy has evolved as much from necessity as scientific observation, since benefits derived from pharmacotherapy currently appear to have reached their peak. Clinical trials of biventricular pacing are establishing morbidity and mortality benefits in heart failure. New challenges in the use of these pacemakers are now arising. These include the accurate diagnosis of ventricular dyssynchrony and, hence, potential responders to the refinement of implantation of the left ventricular lead to the appropriate dyssynchronous ventricular area and optimization of pacemaker programming. This review gives a general overview of the principles and the current evidence for the use of biventricular pacemakers in the treatment of heart failure. In addition, a discussion of current research and future projects is included.
- 10 January 2006
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 4 (1) , 97-109
Biventricular pacing in heart failure: a review
Biventricular pacing has been an exciting recent advance in the management of drug-refractory heart failure. This new therapy has evolved as much from necessity as scientific observation, since benefits derived from pharmacotherapy currently appear to have reached their peak. Clinical trials of biventricular pacing are establishing morbidity and mortality benefits in heart failure. New challenges in the use of these pacemakers are now arising. These include the accurate diagnosis of ventricular dyssynchrony and, hence, potential responders to the refinement of implantation of the left ventricular lead to the appropriate dyssynchronous ventricular area and optimization of pacemaker programming. This review gives a general overview of the principles and the current evidence for the use of biventricular pacemakers in the treatment of heart failure. In addition, a discussion of current research and future projects is included.
- 1 August 2004
- Published by Elsevier in American Heart Journal
- Vol. 148 (2) , 341-347
Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease
- 1 August 2004
- Published by Elsevier in American Heart Journal
- Vol. 148 (2) , 341-347
Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease